drugset / Trial / NCT03314298
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole
NaSingle-groupOpen-labelPrevention
Summary
A single dose trial to evaluate the pharmacokinetics of testosterone and anastrozole from subcutaneous testosterone and anastrozole (T+Ai) in premenopausal women
Timeline
- Start
- 2017-08-14
- Primary completion
- 2018-04-17
- Completion
- 2018-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 4 mg | Subcutaneous |
| Subject | Testosterone | Small molecule | 80 mg | Subcutaneous |